Congo vs Philippines: Access to anti-retroviral drugs, male
Congo
40.0%
in 2024
Philippines
42.0%
in 2024
Congo rank
131st
Philippines rank
128th
Access to anti-retroviral drugs, male over time
- Congo
- Philippines
How they compare
Philippines currently reports 42.0% against 40.0% in Congo, a difference of 2.0%.
That makes Philippines's figure about 1.1 times Congo's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Philippines ahead.
Congo ranks 131st and Philippines ranks 128th of 141 countries.
Across the 3 decades both report, Congo averaged higher in 1 and Philippines in 2.
Head to head by decade
| Decade | Congo | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.9% | 1.3% | 3.6% | Congo |
| 2010s | 20.4% | 21.5% | 1.1% | Philippines |
| 2020s | 31.8% | 41.4% | 9.6% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Congo or Philippines?
- Philippines, at 42.0% against 40.0% in Congo as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Congo and Philippines?
- 2.0%, with Philippines ahead.
- How many years of comparable data are there for Congo and Philippines?
- 25 years are reported by both, from 2000 to 2024.
- How do Congo and Philippines rank globally for access to anti-retroviral drugs, male?
- Congo ranks 131st and Philippines ranks 128th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.